BTOG 2020 | Brain metastases in ALK+ NSCLC

Natasha Leighl

Natasha Leighl, BSc, MMSc, MD, Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto, Canada, discusses the challenge of brain metastases in ALK+ non-small cell lung cancer (NSCLC). She highlights the importance of early treatment with agents that reduce this progression; however, she explains how this leaves fewer options for subsequent lines of treatment. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter